Institutional Ownership
Mineralys Therapeutics Inc
CUSIP 603170101COMMLYSQ1 2026
Institutional Holders
207
13F filers
Shares Held
86.72M
Aggregate institutional
Institutional Value
$2.30B
Q1 2026
Net New Holders
-9
26 new · 35 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions26
Increased97
Decreased52
Sold out35
Institutional Holders
207 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.90M | $214.11M | 0 | Held |
| 2 | Ra Capital Management, L.P. | 7.69M | $208.40M | +369.0K | Added |
| 3 | Samsara Biocapital, LLC | 5.87M | $159.05M | 0 | Held |
| 4 | Fmr LLC | 4.86M | $131.69M | −196.4K | Reduced |
| 5 | Blackrock, Inc. | 4.48M | $121.41M | +153.9K | Added |
| 6 | Wellington Management Group LLP | 3.36M | $91.00M | +2.57M | Added |
| 7 | State Street Corp | 2.94M | $79.53M | −249.1K | Reduced |
| 8 | Caligan Partners LP | 2.77M | $75.11M | 0 | Held |
| 9 | Laurion Capital Management LP | 2.23M | $60.47M | +518.6K | Added |
| 10 | Orbimed Advisors LLC | 2.05M | $55.61M | +1.07M | Added |
197 more institutional holders on Premium
See every fund holding Mineralys Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders